【2h】

Cardiac Valve Replacement

机译:心脏瓣膜置换

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cardiac valve replacement (single or double) was carried out in 138 consecutive patients with valvular heart disease over a six-year period at the Wadsworth Veterans Administration Hospital. All but a few had functional class III or IV disease. Hospital mortality was 3.6 percent.Normothermia, coronary perfusion and beating of the heart were maintained throughout the procedure. All patients were followed at least one year and the average follow-up was four and a half years. The late mortality was 27 percent. Seventy-five percent of the late deaths were due to progressive cardiac disease. The mortality due to prosthetic valve dysfunction was 4 percent.Subjective evaluation of survivors revealed that a high percentage remained symptomatic. Only 50 percent of the total group of patients were significantly improved.The high incidence of late mortality and poor long-term functional results are contrasted to the low operative risk and improved reliability of prosthetic valves. The rationale of delaying operation until functional class III limitation develops is questioned. Earlier operation is recommended before irreversible myocardial hypertrophy and fibrosis develop.
机译:在Wadsworth Veterans Administration Hospital(Wadsworth退伍军人管理局)医院进行了为期六年的连续138例瓣膜性心脏病患者的心脏瓣膜置换术(单次或两次)。除少数外,其余所有人均患有功能性III或IV级疾病。医院死亡率为3.6%。在整个过程中均保持了常温,冠状动脉灌注和心脏跳动。所有患者均接受了至少一年的随访,平均随访期为四年半。晚期死亡率为27%。晚期死亡的百分之七十五是由于进行性心脏病。人工瓣膜功能障碍导致的死亡率为4%。幸存者的主观评估显示,仍有较高的症状征状。仅有50%的患者得到了显着改善。晚期死亡率高和长期功能不良的结果与手术风险低和人工瓣膜可靠性提高形成鲜明对比。有人质疑将操作推迟到三类功能限制发展的原因。建议尽早进行不可逆的心肌肥大和纤维化发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号